Jaringan Laboratorium Medis

Vol. 2 No. 1 (2020): May 2020
Original Articles

Profile of SGOT and SGPT levels in Patients with Pulmonary Tuberculosis

Siti Chairini
Poltekkes Kemenkes Semarang
Widodo
Poltekkes Kemenkes Semarang

Published 2023-11-30

Keywords

  • SGOT,
  • SGPT,
  • Pulmonary TB

How to Cite

Profile of SGOT and SGPT levels in Patients with Pulmonary Tuberculosis. (2023). Jaringan Laboratorium Medis, 2(1), 18-21. https://doi.org/10.31983/jlm.v2i1.6266

CrossMark



Dimensions

If it doesn't Appear, click here



PlumX Metrics



Impact Factor

or, Visit on here

Abstract

Liver disfunction is characterized by increased levels of SGOT and SGPT. The mechanism of liver disfunction by anti-tuberculosis drug (ATD) is not yet clearly known, but several research mention the occurrence of hepatotoxicity which caused by direct effect or through the complex production of drug enzyme which have consequences in cell disfunction as well as membrane disfunction. Hepatotoxicity due to ATD does not occur in each patient, but it could cause liver injury. research objective to find out the description of examination of SGOT and SGPT levels in patients of pulmonary tuberculosis. The research type was descriptive using medical records data and laboratory data of RSUP patients of pulmonary TB in January-March 2020. Research results : the normal SGOT levels in men 6-33 U/L as much as 63,33%, and SGOT > normal 50-66 U/L as much as 2,35%. The normal SGOT levels in women 10-25 U/L as much as 25,88%, and SGOT > normal in women 15-63 U/L as much as 8,24%. The normal SGPT levels in men 3-43 U/L as much as 62,35%, and SGPT > normal 55-65 U/L as much as 3,53%. The normal SGPT levels in women 7-29 U/L as much as 34,12%. Hepatotoxicity based on SGOT levels as many as 9 people (10,59%), namely 2 men (elderly and old man) and 7 women (adolescent, adult, and elderly). Hepatotoxicity based on SGPT levels as many as 3 people (3,53%) in elderly and old man.

Downloads

Download data is not yet available.

References

  1. Aminah.S. (2013). Perbedaan Kadar SGOT, SGPT, Ureum dan kreatinin Pada Penderita TB Paru Setelah Enam Bulan Pengobatan. Jurnal Analis Kesehatan. 2(2):260-269.
  2. Annisa, R., Zarfiardy, A.F, Firdayenti. (2015). Perbandingan Kadar SGPT Pada Pasien Tuberkulosis Paru Sebelum dan Sesudah Intensif di Poliklinik Paru RSUD Arifin Achmad Pekanbaru”. JOM FK, (Online), Vol.2 (2)
  3. Crofton, John, and D. A. Mitchison. (1948). Streptomycin resistence in pulmonary tuberculosis. British Medical Journal 2.4588 : 1009. doi: 10.1136/bmj.2.4588.1009
  4. Indranila KS. (2018). Buku Ajar Tes Fungsi Hati. Fakultas Kedokteran Universitas Diponegoro. Semarang
  5. Kementerian Kesehatan. (2014). Pedoman Nasional Pengendalian Tuberkulosis. Dirjen Pengendalian dan Penyehatan Lingkungan. Jakarta.
  6. Karlina, E., Widodo, W., & Purlinda, D. E. (2019). Biochemistry Mycobacterium Tuberculosis Treated with Anti-Isoniazid Treatment. Jaringan Laboratorium Medis, 1(2), 81-85.
  7. Kochi, A., Vareldzis, B., and Styblo, K. (1993). Multidrug-resisten tuberculosis and its control. Research in microbiology, 144(2): 104-110. https://doi.org/10.1016/0923-2508(93)90023-U
  8. Larrouy-Maumus, G., Marino, L. B., Madduri, A. V., Ragan, T. J., Hunt, D. M., Bassano, L., Gutierrez, M.G., Moody, D.B., Pavan, F. R., and de Carvalho, L. P. S. (2016). Cell-Envelope Remodeling as a Determinant of Phenotypic Antibacterial Tolerance in Mycobacterium tuberculosis. ACS Infectious Diseases 2(5): 352-360. doi.org/10.1021/acsinfecdis.5b00148
  9. Nelwan A R. Palar S. Lombo J C. (2014). Kadar Serum Glutamic Oxaloacetic Transaminase dan Serum Glutamic Pyruric Transaminase Pada Pasien Tuberkulosis Paru Selama Dua Bulan Berjalannya Pemberian Obat Anti Tuberkulosis Kombinasi Tetap. Jurnal e-Clinic (eCl). Vol 2(3).
  10. Sumiati, D., & Budiharjo, T. (2019). BTA Suspect Findings Before and After Knocking on the Doors Program by Cadre Based on Quality of Sputum Samples. Jaringan Laboratorium Medis, 1(1), 34-37.